Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021

造影剤注入装置の世界市場予測(~2021年):CT用造影剤注入器、MRI用造影剤注入器

◆タイトル:Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021
◆商品コード:MAM-MD5244
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年5月10日
◆ページ数:128
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、造影剤注入装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、地域別分析、造影剤注入装置の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The contrast injector market is projected to reach USD 636.1 million by 2021 from USD 445.5 million in 2016, growing at a CAGR of 7.4% in the next five years (2016 to 2021). The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent.
The global contrast injector market is segmented on the basis of product, application, and region. In 2016, North America is expected to account for the largest share of the global contrast injector market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate in the forecast period. The high growth rate of this segment can be attributed to factors such as rising aging population and cancer incidences, expansion of international players in China and India, increasing R&D investments in China, and favorable regulatory changes in New Zealand and Australia.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (market developments (product approvals); product deployment; product launch; and other strategies (grants, award & recognition, investment, expansion, agreements, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the contrast injector market.
 By Company Type: Tier 1: 10%, Tier 2: 63%, Tier 3: 27%
 By Designation: Director Level: 19%, C-level: 28%, Others: 53%
 By Region: North America: 27%, Europe: 27%, APAC: 30%, RoW: 16%

Key players in the global contrast injector market include Bracco Imaging S.p.A (Italy), Bayer HealthCare (Germany), Guerbet Group (France), GE Healthcare (U.S.), ulrich GmbH & Co. KG, (Germany), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), Apollo RT Co., Ltd. (China), VIVID IMAGING (China), and AngioDynamics(U.S.)

Research Coverage:
The report provides a picture of the contrast injector market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by product, application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, product pipeline, and key market strategies.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the products and services offered by top players in the contrast injector market. The report analyzes the contrast media injector by product, application, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the contrast injector market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for contrast injectors across regions
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the contrast injector market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the contrast injector market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15

2 RESEARCH METHODOLOGY 16
2.1 RESEARCH METHODOLOGY STEPS 16
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 17
2.1.1.1 Secondary research 17
2.1.1.1.1 Key data from secondary sources 17
2.1.1.2 Primary research 18
2.1.1.2.1 Key Insights from primary sources 20
2.1.1.3 Key industry insights 21
2.1.2 MARKET SIZE ESTIMATION METHODOLOGY 21
2.1.3 RESEARCH DESIGN 23
2.1.4 MARKET DATA VALIDATION AND TRIANGULATION 24
2.1.5 ASSUMPTIONS 25

3 EXECUTIVE SUMMARY 26
3.1 INTRODUCTION 26
3.2 CONCLUSION 28

4 PREMIUM INSIGHTS 29
4.1 CONTRAST MEDIA INJECTORS: MARKET OVERVIEW 29
4.2 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION AND BY PRODUCT 30
4.3 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION AND BY REGION 31
4.4 GEOGRAPHIC SNAPSHOT: CONTRAST MEDIA INJECTORS MARKET 31

5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Large number of approvals for contrast agents 33
5.2.1.2 Increasing number of public and private diagnostic centers 33
5.2.2 RESTRAINTS 34
5.2.2.1 Risks associated with contrast media injectors 34
5.2.2.2 High cost of contrast media injectors and consumables & accessories 34
5.2.2.3 Reluctance to adopt new technology 35
5.2.3 OPPORTUNITIES 35
5.2.3.1 Technological advancements in contrast media injectors arena 35
5.2.3.1.1 IT-enabled solutions for contrast media injectors 35
5.2.3.1.2 Syringeless and dual-head injectors 35
5.2.3.2 Increasing focus of market players on contrast media injector arena 36
5.2.4 CHALLENGES 36
5.2.4.1 Development of gamma and neutron imaging solutions 36
5.2.4.2 Shortage of and need for highly skilled professionals 37
5.2.4.3 Development of biomarkers 37

6 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT 38
6.1 INTRODUCTION 39
6.2 INJECTOR SYSTEMS 40
6.2.1 CT INJECTOR SYSTEMS 42
6.2.2 MRI INJECTOR SYSTEMS 43
6.2.3 ANGIOGRAPHY INJECTOR SYSTEMS 43
6.3 CONSUMABLES 44
6.3.1 INJECTOR HEADS 45
6.3.1.1 Single head injectors 46
6.3.1.2 Dual head injectors 47
6.3.1.3 Syringeless injectors 47
6.3.2 SYRINGES 48
6.3.3 TUBING 49
6.3.4 OTHER CONSUMABLES 49
6.4 ACCESSORIES 50

7 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION 51
7.1 INTRODUCTION 52
7.2 RADIOLOGY 53
7.3 INTERVENTIONAL CARDIOLOGY 54
7.4 INTERVENTIONAL RADIOLOGY 55

8 CONTRAST MEDIA INJECTORS MARKET, BY REGION 57
8.1 INTRODUCTION 58
8.2 NORTH AMERICA 60

8.2.1 U.S. 63
8.2.1.1 Increasing number of diagnostic imaging tests and centers 63
8.2.1.2 Rising prevalence of chronic diseases and increasing aging population 63
8.2.1.3 Prevalence of Alzheimer’s disease and other dementias 64
8.2.2 CANADA 67
8.2.2.1 Rising aging population, high incidence of cancer, CVD, and diabetes 67
8.2.2.2 MRI and CT examinations likely to boost the market 67
8.2.2.3 Increasing number of cardiac arrest cases 68
8.3 EUROPE 70
8.3.1 EUROPE 3 74
8.3.1.1 Germany: increasing number of diagnostic imaging procedures 74
8.3.1.2 France: increasing incidences and prevalence of cancer 75
8.3.1.3 U.K.: lack of sufficient instruments 75
8.3.2 ROE 77
8.3.2.1 Increased focus of market players on RoE countries 78
8.3.2.2 Russia: Initiatives by government to improve healthcare 78
8.4 ASIA-PACIFIC 81
8.4.1 RISE IN AGING POPULATION AND CANCER INCIDENCE 82
8.4.2 EXPANSION OF INTERNATIONAL PLAYERS IN CHINA AND INDIA 82
8.4.3 FAVORABLE REGULATORY CHANGES IN NEW ZEALAND AND AUSTRALIA 83
8.4.4 HEALTHCARE REFORMS, GOVERNMENT INITIATIVES, AND INVESTMENTS IN CHINA 83
8.5 REST OF THE WORLD 86
8.5.1 LATIN AMERICA 87
8.5.2 THE MIDDLE EAST 88
8.5.3 AFRICA 88

9 COMPETITIVE LANDSCAPE 92
9.1 OVERVIEW 92
9.2 MARKET SHARE ANALYSIS 92
9.2.1 BRACCO IMAGING S.P.A 92
9.2.2 BAYER HEALTHCARE 93
9.2.3 GUERBET GROUP 93
9.3 COMPETITIVE SCENARIO 95
9.3.1 OTHER STRATEGIES 95
9.3.2 PRODUCT DEPLOYMENT 96
9.3.3 PRODUCT LAUNCH 96
9.3.4 MARKET DEVELOPMENTS (PRODUCT APPROVALS) 97

10 COMPANY PROFILES 98
(Overview, Financial*, Products & Services, Strategy, and Developments)
10.1 BAYER AG (MEDRAD INC.) 99
10.2 BRACCO IMAGING S.P.A. 102
10.3 GUERBET GROUP 104
10.4 ULRICH GMBH & CO. KG. 107
10.5 NEMOTO KYORINDO CO., LTD 109
10.6 SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD. (SINOMDT) 110
10.7 APOLLO RT CO., LTD. 111
10.8 VIVID IMAGING 112
10.9 ANGIODYNAMICS (NAVILYST MEDICAL, INC) 113
10.10 GE HEALTHCARE 115
*Details might not be captured in case of unlisted companies.

11 APPENDIX 117
11.1 DISCUSSION GUIDE 117
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 121
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 123
11.4 AVAILABLE CUSTOMIZATIONS 124
11.5 RELATED REPORTS 124
11.6 AUTHOR DETAILS 125

LIST OF TABLES

TABLE 1 GLOBAL CONTRAST MEDIA INJECTORS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 40
TABLE 2 CONTRAST MEDIA INJECTOR SYSTEMS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 41
TABLE 3 CONTRAST MEDIA INJECTOR SYSTEMS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 41
TABLE 4 CONTRAST MEDIA CT INJECTOR SYSTEMS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 42
TABLE 5 CONTRAST MEDIA MRI INJECTOR SYSTEMS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 43
TABLE 6 CONTRAST MEDIA ANGIOGRAPHY INJECTOR SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 44
TABLE 7 CONTRAST MEDIA INJECTOR CONSUMABLES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 44
TABLE 8 CONTRAST MEDIA INJECTOR CONSUMABLES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 45
TABLE 9 CONTRAST MEDIA INJECTOR HEADS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 45
TABLE 10 CONTRAST MEDIA INJECTOR HEADS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 46
TABLE 11 SINGLE HEAD INJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 46
TABLE 12 DUAL HEAD INJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 47
TABLE 13 SYRINGELESS INJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 48
TABLE 14 CONTRAST MEDIA INJECTOR SYRINGES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 48
TABLE 15 CONTRAST MEDIA INJECTOR TUBING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 49
TABLE 16 OTHER CONTRAST MEDIA INJECTOR CONSUMABLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 50
TABLE 17 CONTRAST MEDIA INJECTOR ACCESSORIES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 50
TABLE 18 CONTRAST MEDIA INJECTORS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 53
TABLE 19 CONTRAST MEDIA INJECTORS MARKET SIZE FOR RADIOLOGY, BY REGION,
2014–2021 (USD MILLION) 54
TABLE 20 CONTRAST MEDIA INJECTORS MARKET SIZE FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2014–2021 (USD MILLION) 55
TABLE 21 CONTRAST MEDIA INJECTORS MARKET SIZE FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2014–2021 (USD MILLION) 56
TABLE 22 CONTRAST MEDIA INJECTOR MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 59
TABLE 23 NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 61
TABLE 24 NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 61
TABLE 25 NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION) 61
TABLE 26 NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION) 62
TABLE 27 NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION) 62
TABLE 28 NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 63
TABLE 29 U.S.: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 64
TABLE 30 U.S.: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION) 65
TABLE 31 U.S.: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE,
2014-2021 (USD MILLION) 65
TABLE 32 U.S.: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE,
2014-2021 (USD MILLION) 66
TABLE 33 U.S.: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 66
TABLE 34 CANADA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 68
TABLE 35 CANADA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION) 68
TABLE 36 CANADA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION) 69
TABLE 37 CANADA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION) 69
TABLE 38 CANADA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 70
TABLE 39 EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 72
TABLE 40 EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 72
TABLE 41 EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION) 73
TABLE 42 EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION) 73
TABLE 43 EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION) 74
TABLE 44 EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 74
TABLE 45 EUROPE 3: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 75
TABLE 46 EUROPE 3: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION) 76
TABLE 47 EUROPE 3: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION) 76
TABLE 48 EUROPE 3: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION) 77
TABLE 49 EUROPE 3: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 77
TABLE 50 ROE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 78
TABLE 51 ROE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION) 79
TABLE 52 ROE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE,
2014-2021 (USD MILLION) 79
TABLE 53 ROE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE,
2014-2021 (USD MILLION) 80
TABLE 54 ROE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 80
TABLE 55 ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 83
TABLE 56 ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION) 84
TABLE 57 ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION) 84
TABLE 58 ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION) 85
TABLE 59 ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 85
TABLE 60 ROW: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 89
TABLE 61 ROW: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION) 89
TABLE 62 ROW: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE,
2014-2021 (USD MILLION) 90
TABLE 63 ROW: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE,
2014-2021 (USD MILLION) 90
TABLE 64 ROW: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 91
TABLE 65 KEY PLAYER’S RANKING IN THE CONTRAST MEDIA INJECTOR MARKET (2016) 92
TABLE 66 OTHER STRATEGIES, 2014–2016 95
TABLE 67 PRODUCT DEPLOYMENT, 2014–2016 96
TABLE 68 PRODUCT LAUNCH, 2013–2016 96
TABLE 69 MARKET DEVELOPMENTS (PRODUCT APPROVALS), 2013–2016 97


LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY: GLOBAL CONTRAST MEDIA INJECTORS MARKET 16
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 19
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 19
FIGURE 4 KEY DATA FROM PRIMARY SOURCES 20
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 22
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 22
FIGURE 7 RESEARCH DESIGN: GLOBAL CONTRAST MEDIA INJECTORS MARKET 23
FIGURE 8 DATA TRIANGULATION METHODOLOGY 24
FIGURE 9 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT 26
FIGURE 10 CONTRAST MEDIA INJECTORS MARKET ANALYSIS, BY APPLICATION,
2016 VS. 2021 27
FIGURE 11 ASIA-PACIFIC IS EXPECTED TO WITNESS THE HIGHEST GROWTH IN THE CONTRAST MEDIA INJECTORS MARKET DURING THE FORECAST PERIOD 28
FIGURE 12 NORTH AMERICA ESTIMATED TO ACCOUNT FOR THE LARGEST MARKET SHARE
IN 2016 29
FIGURE 13 CONSUMABLES SEGMENT ESTIMATED TO LEAD THE MARKET IN 2016 30
FIGURE 14 RADIOLOGY IS ESTIMATED TO BE THE LARGEST APPLICATION, 2016 31
FIGURE 15 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 31
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES 32
FIGURE 17 THE CONSUMABLES SEGMENT IS THE FASTEST-GROWING PRODUCT SEGMENT OF THE GLOBAL CONTRAST MEDIA INJECTORS MARKET 39
FIGURE 18 RADIOLOGY TO ACCOUNT FOR THE LARGEST SHARE OF THE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION (2016) 52
FIGURE 19 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE CONTRAST MEDIA INJECTOR MARKET 58
FIGURE 20 NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SNAPSHOT 60
FIGURE 21 PREVALENCE OF ALZHEIMER'S DISEASE IN THE U.S., BY AGE GROUP, 2015 64
FIGURE 22 EUROPE: CONTRAST MEDIA MARKET SNAPSHOT 71
FIGURE 23 ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SNAPSHOT 81
FIGURE 24 ROW: CONTRAST MEDIA MARKET SNAPSHOT 86
FIGURE 25 KEY DEVELOPMENTS OF THE PROMINENT PLAYERS IN THE CONTRAST MEDIA INJECTOR MARKET (2013-2016) 94
FIGURE 26 OTHER STRATEGIES — KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2013 TO 2016 94
FIGURE 27 PRODUCT MIX OF THE PROMINENT PLAYERS IN THE CONTRAST MEDIA INJECTOR MARKET 98
FIGURE 28 BAYER HEALTHCARE: COMPANY SNAPSHOT 99
FIGURE 29 BRACCO IMAGING S.P.A: COMPANY SNAPSHOT (2015) 102
FIGURE 30 GUERBET GROUP: COMPANY SNAPSHOT (2015) 104
FIGURE 31 ANGIODYNAMICS: COMPANY SNAPSHOT (2015) 113
FIGURE 32 GE HEALTHCARE: COMPANY SNAPSHOT 115


【レポートのキーワード】

造影剤注入装置、CT用造影剤注入器、MRI用造影剤注入器、注入器ヘッド、造影剤インジェクター、医療機器

★調査レポート[造影剤注入装置の世界市場予測(~2021年):CT用造影剤注入器、MRI用造影剤注入器] ( Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021 / MAM-MD5244) 販売に関する免責事項
[造影剤注入装置の世界市場予測(~2021年):CT用造影剤注入器、MRI用造影剤注入器] ( Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021 / MAM-MD5244) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆